Evading the acidic environment of the stomach, the absorption of glutathione has become more efficient
Studies show people usually regain weight [archived link] after stopping GLP-1 RAs
Collectively, these extra-hepatic effects create a favorable systemic metabolic environment that indirectly but substantially benefits hepatic steatosis and MASH
52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA
Direct Link Noble, R.C
It is indicated in patients dealing with IBS, GERD, leaky gut, ulcers, Crohns disease as it improves the integrity of the gastric mucosa